1. Scrip

Senegal conference assembles experts to discuss regulatory convergence in Africa

 
• By Ian Schofield

This week, more than 150 regulatory experts and health officials were expected to attend the fourth African Regulatory Conference in Dakar, Senegal, to look at ways of strengthening and aligning regulatory systems in Africa and speeding up drug approvals across the continent.

This week, more than 150 regulatory experts and health officials were expected to attend the fourth African Regulatory Conference in Dakar, Senegal, to look at ways of strengthening and aligning regulatory systems in Africa and speeding up drug approvals across the continent.

Organized by the DIA and the international industry federation IFPMA, with support from the Bill & Melinda Gates Foundation and the World Bank, the 27-28 April event was intended to provide a valuable forum for industry, regulators, the World Health Organization, NGOs and other stakeholders to share

More from Archive

More from Scrip

Which Firms Are Most Exposed To Prasad’s Possible Accelerated Approvals Clampdown?

 
• By Andrew McConaghie

Vaccine and accelerated approvals are expected to face greater scrutiny under new CBER leader Vinay Prasad, but he has promised “no light switch change” to policy, giving some reassurance to companies whose share prices have been battered.

Building Up US Biopharma Manufacturing Will Require Investments In Talent

 
• By Jessica Merrill

Workforce development will be essential to meeting president Trump’s goal to return biopharma manufacturing to the US.

Finance Watch: Deerfield Closes $600m-Plus VC Fund; Gates Speeds Up Health Investments

 
• By Mandy Jackson

Private Company Edition: Deerfield’s third innovations fund will back therapeutics and other opportunities, the Gates Foundation – a sometimes funder of biotech firms – will spend $200bn over the next 20 years, and NewLimit raised a $130m series B round, among other financings.